Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Clin J Pain. 2014 Jul;30(7):557–564. doi: 10.1097/AJP.0000000000000021

Table 2.

The Health Core Sample with new episodes of CNCP#

Total Sample Post-Index Opioid Abuse or Dependence Diagnosis No Post-Index Opioid Abuse or Dependence Diagnosis

N=568,640 N=497 N=568,143

N (%) N (%) N (%)
Opioid Dose and Days Supply
 No opioid use 371,371 (65.3) 150 (30.2) 371,221 (65.30
 Low dose, acute 90,415 (15.9) 111 (22.3) 90,304 (15.9)
 Low dose, chronic 6,902 (1.2) 50 (10.1) 6,852 (1.2)
 Medium dose, acute 83,542 (14.7) 101 (20.3) 83,441 (14.7)
 Medium dose, chronic 3,654 (0.6) 47 (9.5) 3,607 (0.6)
 High dose, acute 12,378 (2.2) 15 (3.0) 12,363 (2.2)
 High dose, chronic 378 (0.1) 23 (4.6) 355 (0.1)
Age in Years
 18–30 65,089 (11.4) 156 (31.4) 64,933 (11.4)
 31–40 112,412 (19.8) 126 (25.4) 112,286 (19.8)
 41–50 154,635 (27.2) 123 (24.7) 154,512 (27.2)
 51–64 167,558 (29.5) 82 (16.5) 167,476 (29.5)
 >=65 68,946 (12.1) 10 (2.0) 68,935 (12.1)
Gender
 Female 331,533 (58.3) 185 (37.2). 331,348 (58.3)
 Male 237,107 (41.7) 312 (62.8) 236,795 (41.7)
# of types of tracer pains (of 5) in the PRE Index period
 None 504,208 (88.7) 448 (90.1) 503,760 (88.7)
 One 58,348 (10.3) 42 (8.5) 58,306 (10.3)
 Two or more 6,084 (1.1) 7 (1.4) 6,077 (1.1)
Number of Non-Tracer Pain Categories
 0 363,779 (64.0) 340 (68.4) 363,439 (64.0)
 1 145,825 (25.6) 105 (21.1) 145,720 (25.6)
 2–3 56,423 (9.9) 47 (9.5) 56,376 (9.9)
 4+ 2,316 (0.5) 5 (1.0) 2,608 (0.5)
Number of Non-Substance Mental Health Disorder Types
 0 525,555 (92.4) 346 (69.6) 525,209 (92.7)
 1 36,659(6.4) 106 (21.3) 36,553 (6.4)
 2+ 5,426 (1.1) 45 (9.1) 6,381 (1.1)
Pre-index Substance Abuse/ Dependence Diagnoses
 Opioid 172 (0.0) 78 (15.7) 94 (0.0)
 Non-Opioid 605 (0.1) 51 (10.3) 554 (0.1)
 Alcohol 1,145 (0.2) 31 (6.2) 1,114 (0.2)
Charlson score - Mean (SD) 0.16 (0.50) 0.16 (0.50) 0.16 (0.50)
#

All independent variables, except the opioid variables (days supply, dose, category type) were measured in the 12 months prior to the index date. Opioid variables were measured in the 12-month period after the index date.